Lepu ScienTech Medical Technology (Shanghai) (HKG:2291) said controlling shareholder Lepu Medical Technology (Beijing) (SHE:300003) sold 11.14 million H-shares through a block trade on Tuesday, according to a same-day Hong Kong bourse filing.
The shares were placed at HK$22.79 each, representing about 3.2% of the company's issued share capital.
Following the sale, Lepu Medical still holds roughly 268.86 million shares, or 77.5% of Lepu ScienTech, including stakes via its subsidiary Beijing Target Medical Technologies.
The company said the disposal was aimed at improving share liquidity and will not affect its operations.